Towards the re-verification of process tank calibrations

Re-verification is needed to ensure that the calibration (the relationship between measured level and measured volume) that is obtained during commissioning hasn’t changed over time. This can be achieved, in part, by metering in solution and correlating with marks identified a priori. Mark identification and correlation are discussed and possible error sources are outlined

Use of Local Image Information in Depth Edge Classification by Humans and Neural Networks

Humans can use local cues to distinguish image edges caused by a depth change from other types of edges (Vilankar et al., 2014). But which local cues? Here we use the SYNS database (Adams et al., 2016) to automatically label edges in images of natural scenes as depth or non-depth. We use this ground truth to identify the cues used by human observers and convolutional neural networks (CNNs) for edge classification. Eight observers viewed square image patches, each centered on an image edge, ranging in width from 0.6 to 2.4 degrees (8 to 32 pixels). Human judgments (depth/non-depth) were compared to responses of a CNN trained on the same task. Human performance improved with patch size (65%-74% correct) but remained well below CNN accuracy (82-86% correct). Agreement between humans and the CNN was above chance but lower than human-human agreement. Decision Variable Correlation (Sebastian & Geisler, in press) was used to evaluate the relationships between depth responses and local edge cues. Humans seem to rely primarily on contrast cues, specifically luminance contrast and red-green contrast across the edge. The CNN also relies on luminance contrast, but unlike humans it seems to make use of mean luminance and red-green intensity as well. These local luminance and color features provide valid cues for depth edge discrimination in natural scenes

Supplemental Report on Nuclear Safeguards Considerations for the Pebble Bed Modular Reactor (PBMR)

Recent reports by Department of Energy National Laboratories have discussed safeguards considerations for the low enriched uranium (LEU) fueled Pebble Bed Modular Reactor (PBMR) and the need for bulk accountancy of the plutonium in used fuel. These reports fail to account effectively for the degree of plutonium dilution in the graphitized-carbon pebbles that is sufficient to meet the International Atomic Energy Agency's (IAEA's) 'provisional' guidelines for termination of safeguards on 'measured discards.' The thrust of this finding is not to terminate safeguards but to limit the need for specific accountancy of plutonium in stored used fuel. While the residual uranium in the used fuel may not be judged sufficiently diluted to meet the IAEA provisional guidelines for termination of safeguards, the estimated quantities of {sup 232}U and {sup 236}U in the used fuel at the target burn-up of {approx}91 GWD/MT exceed specification limits for reprocessed uranium (ASTM C787) and will require extensive blending with either natural uranium or uranium enrichment tails to dilute the {sup 236}U content to fall within specification thus making the PBMR used fuel less desirable for commercial reprocessing and reuse than that from light water reactors. Also the PBMR specific activity of reprocessed uranium isotopic mixture and its A{sub 2} values for effective dose limit if released in a dispersible form during a transportation accident are more limiting than the equivalent values for light water reactor spent fuel at 55 GWD/MT without accounting for the presence of the principal carry-over fission product ({sup 99}Tc) and any possible plutonium contamination that may be present from attempted covert reprocessing. Thus, the potentially recoverable uranium from PBMR used fuel carries reactivity penalties and radiological penalties likely greater than those for reprocessed uranium from light water reactors. These factors impact the economics of reprocessing, but a more significant consideration is that reprocessing technologies for coated particle fuels encased in graphitized-carbon have not progressed beyond laboratory-scale demonstrations although key equipment that has been tested in the past (such as graphite burners and electrolytic disintegration/dissolution devices) are not listed on either the 'Trigger List' or the 'Dual Use List' for mandatory export controls. Finally, if gross burn-up determined from fission product gamma ray inspection of a discharged pebble cannot be correlated acceptably with predicted plutonium content of the pebble, development and testing may be required on detector concepts for more directly measuring the plutonium content in a discharged pebble to ensure that its placement in the spent fuel storage tanks is for an acceptable 'measured discard' of diluted plutonium

Advanced Safeguards Approaches for New TRU Fuel Fabrication Facilities

This second report in a series of three reviews possible safeguards approaches for the new transuranic (TRU) fuel fabrication processes to be deployed at AFCF – specifically, the ceramic TRU (MOX) fuel fabrication line and the metallic (pyroprocessing) line. The most common TRU fuel has been fuel composed of mixed plutonium and uranium dioxide, referred to as “MOX”. However, under the Advanced Fuel Cycle projects custom-made fuels with higher contents of neptunium, americium, and curium may also be produced to evaluate if these “minor actinides” can be effectively burned and transmuted through irradiation in the ABR. A third and final report in this series will evaluate and review the advanced safeguards approach options for the ABR. In reviewing and developing the advanced safeguards approach for the new TRU fuel fabrication processes envisioned for AFCF, the existing international (IAEA) safeguards approach at the Plutonium Fuel Production Facility (PFPF) and the conceptual approach planned for the new J-MOX facility in Japan have been considered as a starting point of reference. The pyro-metallurgical reprocessing and fuel fabrication process at EBR-II near Idaho Falls also provided insight for safeguarding the additional metallic pyroprocessing fuel fabrication line planned for AFCF

Effects of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparison with baboon data.

BackgroundAlthough studies involving preterm infants ≤34 weeks gestation report a decreased incidence of patent ductus arteriosus after antenatal betamethasone, studies involving younger gestation infants report conflicting results.MethodsWe used preterm baboons, mice, and humans (≤276/7 weeks gestation) to examine betamethasone's effects on ductus gene expression and constriction both in vitro and in vivo.ResultsIn mice, betamethasone increased the sensitivity of the premature ductus to the contractile effects of oxygen without altering the effects of other contractile or vasodilatory stimuli. Betamethasone's effects on oxygen sensitivity could be eliminated by inhibiting endogenous prostaglandin/nitric oxide signaling. In mice and baboons, betamethasone increased the expression of several developmentally regulated genes that mediate oxygen-induced constriction (K+ channels) and inhibit vasodilator signaling (phosphodiesterases). In human infants, betamethasone increased the rate of ductus constriction at all gestational ages. However, in infants born ≤256/7 weeks gestation, betamethasone's contractile effects were only apparent when prostaglandin signaling was inhibited, whereas at 26-27 weeks gestation, betamethasone's contractile effects were apparent even in the absence of prostaglandin inhibitors.ConclusionsWe speculate that betamethasone's contractile effects may be mediated through genes that are developmentally regulated. This could explain why betamethasone's effects vary according to the infant's developmental age at birth

Distribution of Introns in Fungal Histone Genes

Saccharomycotina and Taphrinomycotina lack intron in their histone genes, except for an intron in one of histone H4 genes of Yarrowia lipolytica. On the other hand, Basidiomycota and Perizomycotina have introns in their histone genes. We compared the distributions of 81, 47, 79, and 98 introns in the fungal histone H2A, H2B, H3, and H4 genes, respectively. Based on the multiple alignments of the amino acid sequences of histones, we identified 19, 13, 31, and 22 intron insertion sites in the histone H2A, H2B, H3, and H4 genes, respectively. Surprisingly only one hot spot of introns in the histone H2A gene is shared between Basidiomycota and Perizomycotina, suggesting that most of introns of Basidiomycota and Perizomycotina were acquired independently. Our findings suggest that the common ancestor of Ascomycota and Basidiomycota maybe had a few introns in the histone genes. In the course of fungal evolution, Saccharomycotina and Taphrinomycotina lost the histone introns; Basidiomycota and Perizomycotina acquired other introns independently. In addition, most of the introns have sequence similarity among introns of phylogenetically close species, strongly suggesting that horizontal intron transfer events between phylogenetically distant species have not occurred recently in the fungal histone genes

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) is faster and biologically more informative. FCM-MRD performed in 18 laboratories across seven countries was used for risk stratification of 1487 patients with BCP-ALL enrolled in the NOPHO ALL2008 protocol. When no informative FCM-marker was available, risk stratification was based on real-time quantitative PCR. An informative FCM-marker was found in 96.2% and only two patients (0.14%) had non-informative FCM and non-informative PCR-markers. The overall 5-year event-free survival was 86.1% with a cumulative incidence of relapse (CIR5y) of 9.5%. FCM-MRD levels on days 15 (HzR 4.0, p 10(-4) associated with a CIR5y = 22.1%. In conclusion, FCM-MRD performed in a multicenter setting is a clinically useful method for MRD-based treatment stratification in BCP-ALL.Peer reviewe